Related references
Note: Only part of the references are listed.Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer
Chameera Ekanayake Weeramange et al.
CANCER (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Organoid Models for Precision Cancer Immunotherapy
Cai-Ping Sun et al.
FRONTIERS IN IMMUNOLOGY (2022)
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Malia Alexandra Foo et al.
BIOMARKER RESEARCH (2022)
Organoids in lung cancer: A teenager with infinite growth potential
Yiming Xu et al.
LUNG CANCER (2022)
Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe et al.
HELIYON (2022)
Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors
Mark Gormley et al.
BRITISH DENTAL JOURNAL (2022)
Challenges in diagnosing head and neck cancer in primary health care
Markus Nieminen et al.
ANNALS OF MEDICINE (2021)
Roles of mesenchymal stromal cells in the head and neck cancer microenvironment
Marcelo Coutinho de Miranda et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Genetic engineering in organoids
Isaree Teriyapirom et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
Chao Liu et al.
NPJ PRECISION ONCOLOGY (2021)
Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer
Yenkai Lim et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Patient-derived xenografts and organoids model therapy response in prostate cancer
Sofia Karkampouna et al.
NATURE COMMUNICATIONS (2021)
Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform
Bo Pan et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2021)
Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy
Jingjing Qu et al.
CANCER COMMUNICATIONS (2021)
Establishment of Colorectal Cancer Organoids in Microfluidic-Based System
Diana Pinho et al.
MICROMACHINES (2021)
Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
Yuzuka Kanno et al.
FRONTIERS IN ONCOLOGY (2021)
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
Shaodong Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers
Chameera Ekanayake Weeramange et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2021)
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
Ye Yao et al.
CELL STEM CELL (2020)
Could 3D models of cancer enhance drug screening?
Virginia Brancato et al.
BIOMATERIALS (2020)
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
Ian R. Powley et al.
BRITISH JOURNAL OF CANCER (2020)
Organoids to study immune functions, immunological diseases and immunotherapy
Wenrui Ye et al.
CANCER LETTERS (2020)
Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery
Rolvix H. Patterson et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2020)
Prioritizing Gene Cascading Paths to Model Colorectal Cancer Through Engineered Organoids
Yanyan Ping et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies
Hui Yi Chew et al.
CELL (2020)
Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma
Hui Chen et al.
GYNECOLOGIC ONCOLOGY (2020)
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
Meghan G. Haney et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
An Occult HPV-Driven Oropharyngeal Squamous Cell Carcinoma Discovered Through a Saliva Test
Kai Dun Tang et al.
FRONTIERS IN ONCOLOGY (2020)
Organoid models of childhood kidney tumours
Ariadne H. A. G. Ooms et al.
NATURE REVIEWS UROLOGY (2020)
Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma
Kai D. Tang et al.
CANCER SCIENCE (2020)
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
Apostolos Klinakis et al.
EBIOMEDICINE (2020)
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
Takehito Yamamoto et al.
CANCERS (2020)
Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening
Larisa Gorican et al.
CELLS (2020)
EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations
Hina S. Rehmani et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Human organoids: model systems for human biology and medicine
Jihoon Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Organoid Models of Tumor Immunology
Kanako Yuki et al.
TRENDS IN IMMUNOLOGY (2020)
Establishment of patient-derived cancer organoids for drug-screening applications
Else Driehuis et al.
NATURE PROTOCOLS (2020)
Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC)
Nabil F. Saba et al.
PLOS ONE (2020)
Head and Neck Cancer
Laura Q. M. Chow
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Advancing precision medicine with personalized drug screening
Kirill Gorshkov et al.
DRUG DISCOVERY TODAY (2019)
Large-scale compound screens and pharmacogenomic interactions in cancer
Ultan McDermott
CURRENT OPINION IN GENETICS & DEVELOPMENT (2019)
Mouse and human urothelial cancer organoids: A tool for bladder cancer research
Jasper Mullenders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
Vanathi Perumal et al.
CANCERS (2019)
Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids
Ana C. F. Bolhaqueiro et al.
NATURE GENETICS (2019)
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy
Else Driehuis et al.
CANCER DISCOVERY (2019)
Xenograft and organoid model systems in cancer research
Margit Bleijs et al.
EMBO JOURNAL (2019)
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi et al.
CELL DEATH & DISEASE (2019)
Predictive Potential of Head and Neck Squamous Cell Carcinoma Organoids
Sarah J. Hill et al.
CANCER DISCOVERY (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Tongyan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
Panagiota Economopoulou et al.
FRONTIERS IN ONCOLOGY (2019)
Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay
Alba Costales-Carrera et al.
MARINE DRUGS (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells
Jose M. Ayuso et al.
SCIENTIFIC REPORTS (2019)
Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells
Philipp Woersdoerfer et al.
SCIENTIFIC REPORTS (2019)
Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy
Else Driehuis et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment
Gilles S. van Tienderen et al.
CANCERS (2019)
The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer
Styliani Melissaridou et al.
CANCER CELL INTERNATIONAL (2019)
A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer
Aparna Padhye et al.
SCIENTIFIC REPORTS (2019)
Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells
Takashi Kijima et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Russell W. Jenkins et al.
CANCER DISCOVERY (2018)
Patient-derived organoid models help define personalized management of gastrointestinal cancer
M. R. Aberle et al.
BRITISH JOURNAL OF SURGERY (2018)
The Financial Burden and Distress of Patients with Cancer: Understanding and Stepping-Up Action on the Financial Toxicity of Cancer Treatment
Pricivel M. Carrera et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Development of an in vitro cell-sheet cancer model for chemotherapeutic screening
Jaewang Lee et al.
THERANOSTICS (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
Precision medicine in head and neck cancer
Orit Kaidar-Person et al.
DRUG RESISTANCE UPDATES (2018)
Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity
Noriaki Tanaka et al.
ORAL ONCOLOGY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations
Julia Jabs et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
Livin enhances chemoresistance in head and neck squamous cell carcinoma
Tae Mi Yoon et al.
ONCOLOGY REPORTS (2017)
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
Chun-mei Kuang et al.
CELL DEATH & DISEASE (2017)
Modeling nasopharyngeal carcinoma in three dimensions
Prabu Siva Sankar et al.
ONCOLOGY LETTERS (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
Three-Dimensional Cell Cultures in Drug Discovery and Development
Ye Fang et al.
SLAS DISCOVERY (2017)
Tracking the tumor invasion front using long-term fluidic tumoroid culture
Koh Meng Aw Yong et al.
SCIENTIFIC REPORTS (2017)
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
Fleur Weeber et al.
CELL CHEMICAL BIOLOGY (2017)
Ex vivo tumor culture systems for functional drug testing and therapy response prediction
Titia G. Meijer et al.
FUTURE SCIENCE OA (2017)
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
T. R. Shenoy et al.
ANNALS OF ONCOLOGY (2017)
Overview of the 8th Edition TNM Classification for Head and Neck Cancer
Shao Hui Huang et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer
Jan Hagemann et al.
ANTICANCER RESEARCH (2017)
A Pilot Study into the Association between Oral Health Status and Human Papillomavirus16 Infection
Charles Xiaohang Sun et al.
DIAGNOSTICS (2017)
Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
Yenkai Lim et al.
BMC CANCER (2016)
Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience
Nerina Denaro et al.
CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY (2016)
Organoids derived from digestive tract, liver, and pancreas
An Tao Xu et al.
JOURNAL OF DIGESTIVE DISEASES (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The development of a liquid biopsy for head and neck cancers
Henri Schmidt et al.
ORAL ONCOLOGY (2016)
In Vitro Tumor Models: Advantages, Disadvantages, variables, and Selecting the Right Platform
Moriah E. Katt et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: A meta-analysis
Ma Xuelei et al.
ORAL ONCOLOGY (2015)
Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures
Lorenz Kadletz et al.
ONCOLOGY LETTERS (2015)
Liver cancer oncogenomics: opportunities and dilemmas for clinical applications
Jens U. Marquardt et al.
HEPATIC ONCOLOGY (2015)
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
Rasheena Edmondson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition
S. Warrier et al.
CANCER GENE THERAPY (2014)
Cancer Cell Lines for Drug Discovery and Development
Jennifer L. Wilding et al.
CANCER RESEARCH (2014)
Association of Drug Transporter Expression with Mortality and Progression-Free Survival in Stage IV Head and Neck Squamous Cell Carcinoma
Rolf Warta et al.
PLOS ONE (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
The Economic Burden of Toxicities Associated with Cancer Treatment: Review of the Literature and Analysis of Nausea and Vomiting, Diarrhoea, Oral Mucositis and Fatigue
Alan Carlotto et al.
PHARMACOECONOMICS (2013)
Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures
Young Chang Lim et al.
EXPERIMENTAL CELL RESEARCH (2012)
The molecular pathogenesis of head and neck squamous cell carcinoma
S. Michael Rothenberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
Tai-Jan Chiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer
Jumpei Kondo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
V. Gregoire et al.
ANNALS OF ONCOLOGY (2010)
Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin
Andrea Haegebarth et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells
T. Mizumachi et al.
ONCOGENE (2008)
In vitro three-dimensional tumor microenvironment models for anticancer drug discovery
Keiran S. M. Smalley et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Immortalized cells as experimental models to study cancer
JS Boehm et al.
CYTOTECHNOLOGY (2004)
Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck:: long-term results of a phase II trial
R Hitt et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
